Pfizer seeks authorization for its COVID-19 antiviral pill and booster shot expansion

The FDA and CDC could expand eligibility of the Pfizer booster shot as early as this week. The drugmaker is also seeking emergency use authorization for its COVID-19 antiviral pill, Paxlovid. CBS News’ Naomi Ruchim reports, and then Dr. William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, joins CBSN’s Tanya Rivero to discuss the latest progress in the fight against the coronavirus pandemic.

Share this:

What do you think?

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fasting two days a week helps obese people keep off the weight, study finds

Democrats’ SALT Proposals Would Give Tax Windfall To Rich Americans On Both Coasts